Suresh K. Durgam Intra Cellular Therapies, Inc. (ITCI) insider trading activity

ITCI Quotes by TradingView

Suresh K. Durgam is EVP, Chief Medical Officer of Intra-Cellular Therapies, Inc.. Currently has a direct ownership of 19,803 shares of ITCI, which is worth approximately $1.71 Million. The most recent transaction as insider was on Jan 10, 2022, when has been sold 6,870 shares (Common Stock) at a price of $40.65 per share, resulting in proceeds of $279,266. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.8K
0% 3M change
6.86% 12M change
Total Value Held $1.71 Million

Suresh K. Durgam Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 10 2022
SELL
Open market or private sale
$279,266 $40.65 p/Share
6,870 Reduced 18.98%
29,327 Common Stock
Jan 08 2022
BUY
Exercise of conversion of derivative security
-
13,093 Added 26.56%
36,197 Common Stock
Feb 19 2021
SELL
Open market or private sale
$106,817 $39.07 p/Share
2,734 Reduced 10.58%
23,104 Common Stock
Feb 18 2021
BUY
Exercise of conversion of derivative security
-
8,354 Added 24.43%
25,838 Common Stock
Jan 11 2021
SELL
Open market or private sale
$139,176 $31.87 p/Share
4,367 Reduced 19.99%
17,484 Common Stock
Jan 08 2021
BUY
Exercise of conversion of derivative security
-
13,092 Added 37.47%
21,851 Common Stock
SKD

Suresh K. Durgam

EVP, Chief Medical Officer
New York, NY

Track Institutional and Insider Activities on ITCI

Follow Intra-Cellular Therapies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITCI shares.

Notify only if

Insider Trading

Get notified when an Intra Cellular Therapies, Inc. insider buys or sells ITCI shares.

Notify only if

News

Receive news related to Intra-Cellular Therapies, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ITCI